Nuveen LLC acquired a new position in shares of SunOpta, Inc. (NASDAQ:STKL - Free Report) TSE: SOY in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 315,492 shares of the company's stock, valued at approximately $1,533,000. Nuveen LLC owned 0.27% of SunOpta as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in STKL. Quarry LP bought a new stake in SunOpta in the fourth quarter valued at $36,000. Bayesian Capital Management LP boosted its stake in shares of SunOpta by 15.2% in the 4th quarter. Bayesian Capital Management LP now owns 11,536 shares of the company's stock valued at $89,000 after purchasing an additional 1,523 shares in the last quarter. EP Wealth Advisors LLC grew its holdings in shares of SunOpta by 18.7% in the 4th quarter. EP Wealth Advisors LLC now owns 14,730 shares of the company's stock worth $113,000 after purchasing an additional 2,316 shares during the last quarter. Algert Global LLC acquired a new stake in shares of SunOpta during the 4th quarter worth about $141,000. Finally, Corton Capital Inc. bought a new position in SunOpta during the 4th quarter valued at about $150,000. Institutional investors own 85.39% of the company's stock.
Insider Buying and Selling at SunOpta
In other news, CEO Brian W. Kocher bought 10,000 shares of the stock in a transaction on Tuesday, June 10th. The stock was purchased at an average price of $5.72 per share, with a total value of $57,200.00. Following the completion of the purchase, the chief executive officer owned 10,000 shares of the company's stock, valued at approximately $57,200. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.90% of the stock is currently owned by company insiders.
SunOpta Price Performance
SunOpta stock traded up $0.04 on Wednesday, reaching $6.22. The company's stock had a trading volume of 224,779 shares, compared to its average volume of 857,648. SunOpta, Inc. has a twelve month low of $3.64 and a twelve month high of $8.11. The company has a market cap of $730.52 million, a price-to-earnings ratio of -103.58 and a beta of 1.35. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.39 and a current ratio of 0.96. The business's fifty day moving average price is $6.17 and its 200 day moving average price is $5.68.
SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.04 earnings per share for the quarter, beating analysts' consensus estimates of $0.02 by $0.02. SunOpta had a negative net margin of 0.66% and a positive return on equity of 12.82%. The business had revenue of $191.49 million during the quarter, compared to analyst estimates of $185.36 million. Equities analysts expect that SunOpta, Inc. will post 0.13 earnings per share for the current fiscal year.
SunOpta Company Profile
(
Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
See Also

Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.